JPRN-UMIN000012216已完成未知
Treatment with supplementary L-ornithine in patients with pressure ulcers. - L-ornithine ingestion for pressure ulcers
Kurume University School of Medicine0 个研究点目标入组 10 人开始时间: 2013年11月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •*Patients with history of high hypersensitivity *Patients with renal disease who is inadequate for the study *Patients with following conditions which may affect the blood albumin level irrelevantly to nutritional status -Malignancy -Acute inflammatory diseases such as infectious disease -Serious hepatic disorders such as cirrhosis -Severe burn or injury -History of metabolic disorders of amino acid *Patients at risk of acquiring allergy related the study *Patients with remarkable higher or lower laboratory values or physiological measurement than reference value *Patients included in other clinical studies within 3 months or in process *Patients with other conditions which principal investigator consider inadequate such as routine users of similar food (e.g. amino acid supplement)
研究者
相似试验
招募中
不适用
Plasmapheresis plus LOLA in liver failure of children.CTRI/2023/02/049867Institute of Liver and Biliary Sciences
招募中
4 期
Role of L-Ornithine L-Aspartate in improving acute encephalopathy (altered sensorium) in patients with Liver CirrhosisCTRI/2013/02/003360Department of Gastroenterology164
已完成
不适用
Safety assessment of oral intake of L-Ornithine: Systematic reviewHuman who has received L-Ornithine by oralJPRN-UMIN000033371Yokohama University of Pharmacy100
进行中（未招募）
1 期
Study to test the effect of the drug L-ornithine.L-aspertate (LOLA) on microorganisms in the digestive tract in patients with liver cirrhosis (damage of the liver due to liver disease)iver cirrhosis with covert or overt hepatic encephalopathy (grade 0-2)MedDRA version: 20.0Level: LLTClassification code 10024667Term: Liver cirrhosisSystem Organ Class: 100000004871MedDRA version: 20.0Level: LLTClassification code 10014630Term: Encephalopathy hepaticSystem Organ Class: 100000004852EUCTR2022-002924-11-ATCBmed GmbH55
招募中
不适用
Preliminary Clinical Study on the Effect of L-ornithine on the Efficacy of Ustekinumab in Patients With Crohn's DiseaseMild to Severe Crohns DiseaseNCT06455267The Third Xiangya Hospital of Central South University50